Negative Pleural Suction for Tube Thoracostomy in Patients With Chest Trauma
Efficacy of Negative Pleural Suction in Tube Thoracostomy for Patients With Penetrating and/or Blunt Chest Trauma: a Randomized Clinical Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Antioquia
-
Medellin, Antioquia, Colombia
- Departamento de Cirugía, Universidad de Antioquia, San Vicente Fundación Hospital Universitario
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pneumothorax after penetrating o blunt chest trauma
- Hemothorax after penetrating o blunt chest trauma
- Hemopneumothorax after penetrating o blunt chest trauma
- Require tube thoracostomy
Exclusion Criteria:
- Invasive mechanical ventilation
- Emergent Surgery (thoracoscopy, open thoracotomy)
- Chronic pulmonary diseases (COPD, CRPD)
- Severe traumatic brain injury
- Glasgow coma scale upon arrival <8/15
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: With negative pleural suction
Patients are put on negative pleural suction at - 20 cm H2O
|
|
|
Active Comparator: With water seal
Patients al left on water seal only
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Lenght of Hospital stay
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of persistent bronchopleural fistulae
Time Frame: 30 days
|
30 days
|
|
Incidence of coagulated Hemothorax
Time Frame: 30 days
|
30 days
|
|
Incidence of empyema
Time Frame: 30 days
|
30 days
|
|
Incidence of recurrent pneumothorax
Time Frame: 30 days
|
30 days
|
|
Number of patients necessitating surgical interventions (includes new thoracostomy, thoracoscopy and open thoracotomy)
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Camila Mejia, Resident, General Surgery, Universidad de Antioquia
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 01UDEACx2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.